Novartis
NVS
#57
Rank
A$381.77 B
Marketcap
A$198.97
Share price
-0.20%
Change (1 day)
29.84%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$94.14 Billion

According to Novartis's latest financial reports the company's total liabilities are A$94.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novartis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$93.44 B19.67%
2023-12-31A$78.07 B-8.44%
2022-12-31A$85.27 B-3.36%
2021-12-31A$88.24 B-4.59%
2020-12-31A$92.48 B3.07%
2019-12-31A$89.72 B-5.48%
2018-12-31A$94.92 B25.92%
2017-12-31A$75.38 B-1.62%
2016-12-31A$76.62 B2.55%
2015-12-31A$74.72 B12.12%
2014-12-31A$66.64 B14.8%
2013-12-31A$58.05 B9.83%
2012-12-31A$52.85 B5.12%
2011-12-31A$50.28 B-4.62%
2010-12-31A$52.71 B24.48%
2009-12-31A$42.34 B7.24%
2008-12-31A$39.49 B32.51%
2007-12-31A$29.80 B-12.06%
2006-12-31A$33.88 B0.93%
2005-12-31A$33.57 B22.72%
2004-12-31A$27.36 B8.19%
2003-12-31A$25.28 B-14.63%
2002-12-31A$29.62 B2.52%
2001-12-31A$28.89 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Merck
MRK
A$116.88 B 24.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$174.08 B 84.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 81.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$99.40 B 5.58%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
A$92.26 B-2.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$49.08 B-47.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
A$117.86 B 25.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$49.55 B-47.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$103.10 B 9.51%๐Ÿ‡ฌ๐Ÿ‡ง UK